InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
4
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
-2.8%
Across 10 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by HOMBACH ROBERT J., Director. Officer active across 6 companies, notably Biomarin Pharmaceutical INC. In total, 17 reports have been logged. Breakdown: 4 buys · 0 sell. Total volume traded: €45k. Activity tracked since 25 May 2021. The latest transaction was filed on 20 May 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations17 total
6,650 shares0Common StockSEC:0001048477-25-000074:0
2,844 shares0Common Stock par value $0.01 per shareSEC:0000950170-25-034740:0
13,839 shares0Common StockSEC:0000947871-25-000184:0
4,720 shares0Common StockSEC:0001048477-24-000106:0
11,455 shares0Common StockSEC:0000947871-24-000108:0
4,190 shares0Common StockSEC:0001209191-23-031971:0
6,979 shares0Common StockSEC:0001209191-23-008441:0
4,980 shares0Common StockSEC:0001567619-22-011794:0
6,024 shares0Common StockSEC:0001209191-22-023177:0
5,400 shares@ US$2.4025.0% of flowCommon StockSEC:0001415889-21-005223:0
Ideal exit: 8 Aug 2022 (T+270)
5,400 shares@ US$2.4025.0% of flowCommon StockSEC:0001415889-21-005223
Ideal exit: 8 Aug 2022 (T+270)
5,400 shares@ US$2.4025.0% of flowCommon StockSEC:0001415889-21-005202:0
Ideal exit: 8 Aug 2022 (T+270)
5,400 shares@ US$2.4025.0% of flowCommon StockSEC:0001415889-21-005202
Ideal exit: 8 Aug 2022 (T+270)
1,308 shares0Common StockSEC:0001170010-21-000150:0
1,308 shares0Common StockSEC:0001170010-21-000150
5,120 shares0Common StockSEC:0001567619-21-011309:0
5,120 shares0Common StockSEC:0001567619-21-011309
17 of 17 declarations
About HOMBACH ROBERT J.
Robert J. Hombach is a Board Member at BioMarin Pharmaceutical Inc., CarMax Inc., and Aptinyx Inc. With a strong background in the pharmaceutical and automotive industries, he contributes to the governance and strategy of these companies. His role includes overseeing performance and evaluating growth opportunities.
